ABSTRACT
Objective@#To analyze characteristics of virus infections in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD), and to analyze the role of virus infection in acute exacerbations of COPD.@*Methods@#Totally 193 patients of COPD with acute exacerbations admitted to the Hospital of Sichuan Provincial Armed Police Force from April 2015 to March 2016 were enrolled as group A, and 50 patients of COPD in stable stage in the same period were enrolled as group B. IgM antibodies to respiratory syncytial virus, adenovirus, parainfluenza virus, influenza A virus, and influenza B virus in two groups were detected. General conditions and total virus infection rate were analyzed. Infection rates of each virus in group A were calculated. Proportion of single virus infection, two virus infections and several virus infections in group A with virus infection were calculated. Virus infection rates in different seasons in group A were also analyzed.@*Results@#There was no significant difference in age, sex, and course of disease between the two groups(P>0.05). The virus infection rate of group A was 13.47%, which was higher than that of group B(χ2=5.29, P<0.05). The most common virus found in group A was influenza B virus(infection rate 12.44%), followed by influenza A virus(infection rate 7.78%), parainfluenza virus(infection rate 7.25%), adenovirus(infection rate 2.63%), respiratory syncytial virus(infection rate 1.32%). Single virus infection accounted for 34.6% of acute exacerbation COPD patients with virus infection, and two virus infections accounted for 15.4%, and three or more virus infections accounted for 50%. Virus infection rate in summer and autumn were higher than that in winter and spring, but the differences were not statistically significant(P>0.05).@*Conclusions@#This study showed that 14.37% of patients with acute exacerbations of COPD had viral infections, and most of them were infected with two or more viruses. Virus infection may play an important role in the acute exacerbation of COPD, and we need to pay attention to the prevention and treatment of virus infection in patients with COPD.
ABSTRACT
Objective To analyze the prognostic value of vascular endothelial growth factor in acute leukemia .Methods 73 pa-tients with acute leukemia as the leukemia group and 80 patients as the control group were selected .The serum and bone marrow tissue taken by puncture biopsy of posterior superior iliac spine of the leukemia group were collected The serum of the control group was collected and compared .The expression of vascular endothelial growth factor was detected by immunohistochemistry .Results The acute leukemia patients with positive and negative serum VEGF or with positive and negative bone marrow VEGF were fol-lowed .The positive expression of serum VEGF was found in 19 recurrent cases of acute myeloid leukemia (57 .58% ) and the nega-tive expression of serum VEGF was found in 1 recurrent cases (20 .00% ) .The recurrence rate in patients with positive serum VEGF was higher than that in patients with negative serum VEGF ,and the difference was statistically significant (P<0 .05);the positive expression of serum VEGF was found in 16 recurrent cases of acute lymphoblastic leukemia (51 .62% );the positive expres-sion of bone marrow VEGF was found in 17 recurrent cases of acute myeloid leukemia and 17 recurrent cases of acute lymphoblastic leukemia respectively (48 .57% ) .The serum VEGF level and the bone marrow VEGF were measured on follow-up one year after treatment ,which showed the levels of recurrent cases of acute myeloid leukemia and acute lymphoblastic leukemia were all higher than those of Remission patients ,and the difference was statistically significant (P< 0 .01) .Conclusion The levels of VEGF in blood and bone marrow cells can be highly expressed in the initial treatment and recurrence of acute leukemia ,especially in the re-lapsed condition ,the expression level is higher ,but the expression level is significantly decreased in the remission state .Increased expression of VEGF in blood and bone marrow cells may help to predict an increased risk of recurrence .